These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 19010295)

  • 21. Antioxidant therapy in multiple sclerosis.
    Mirshafiey A; Mohsenzadegan M
    Immunopharmacol Immunotoxicol; 2009; 31(1):13-29. PubMed ID: 18763202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tetrathiomolybdate in the treatment of acute hepatitis in an animal model for Wilson disease.
    Klein D; Arora U; Lichtmannegger J; Finckh M; Heinzmann U; Summer KH
    J Hepatol; 2004 Mar; 40(3):409-16. PubMed ID: 15123354
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thalidomide derivatives for the treatment of neuroinflammation.
    Contino-Pépin C; Parat A; Patinote C; Roscoe WA; Karlik SJ; Pucci B
    ChemMedChem; 2010 Dec; 5(12):2057-64. PubMed ID: 20936622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tracing copper-thiomolybdate complexes in a prospective treatment for Wilson's disease.
    Zhang L; Lichtmannegger J; Summer KH; Webb S; Pickering IJ; George GN
    Biochemistry; 2009 Feb; 48(5):891-7. PubMed ID: 19146437
    [TBL] [Abstract][Full Text] [Related]  

  • 25. VEGF and angiogenesis in acute and chronic MOG((35-55)) peptide induced EAE.
    Roscoe WA; Welsh ME; Carter DE; Karlik SJ
    J Neuroimmunol; 2009 Apr; 209(1-2):6-15. PubMed ID: 19233483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of tetrathiomolybdate and penicillamine on brain hydroxyl radical and free copper levels: a microdialysis study in vivo.
    Zhang JW; Liu JX; Hou HM; Chen DB; Feng L; Wu C; Wei LT; Li XH
    Biochem Biophys Res Commun; 2015 Feb; 458(1):82-5. PubMed ID: 25634697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The promise of copper lowering therapy with tetrathiomolybdate in the cure of cancer and in the treatment of inflammatory disease.
    Brewer GJ
    J Trace Elem Med Biol; 2014 Oct; 28(4):372-8. PubMed ID: 25194954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuropathic pain behaviours in a chronic-relapsing model of experimental autoimmune encephalomyelitis (EAE).
    Olechowski CJ; Truong JJ; Kerr BJ
    Pain; 2009 Jan; 141(1-2):156-64. PubMed ID: 19084337
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lower motor neuron loss in multiple sclerosis and experimental autoimmune encephalomyelitis.
    Vogt J; Paul F; Aktas O; Müller-Wielsch K; Dörr J; Dörr S; Bharathi BS; Glumm R; Schmitz C; Steinbusch H; Raine CS; Tsokos M; Nitsch R; Zipp F
    Ann Neurol; 2009 Sep; 66(3):310-22. PubMed ID: 19798635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vitamin D as an immune modulator in multiple sclerosis, a review.
    Smolders J; Damoiseaux J; Menheere P; Hupperts R
    J Neuroimmunol; 2008 Feb; 194(1-2):7-17. PubMed ID: 18177949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Uric acid as a scavenger in oxidative stress].
    Staub M
    Orv Hetil; 1999 Feb; 140(6):275-9. PubMed ID: 10071505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An antibody to IP-10 is a potent antagonist of cell migration in vitro and in vivo and does not affect disease in several animal models of inflammation.
    Byrne FR; Winters A; Brankow D; Hu S; Juan T; Steavenson S; Doellgast G; Kuchimanchi K; Brown H; Anderson S; Smelt S; Sullivan T; Alcorn D; Tocker J; Dean C; Macmaster J; Kirchner J; Buys J; Manoukian R; Jiao E; Zou X; Campanella GS; Siu G
    Autoimmunity; 2009 Mar; 42(3):171-82. PubMed ID: 19301198
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tetrathiomolybdate anticopper therapy for Wilson's disease inhibits angiogenesis, fibrosis and inflammation.
    Brewer GJ
    J Cell Mol Med; 2003; 7(1):11-20. PubMed ID: 12767257
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute neuroinflammation in Lewis rats - a model for acute multiple sclerosis relapses.
    Schneider C; Schuetz G; Zollner TM
    J Neuroimmunol; 2009 Aug; 213(1-2):84-90. PubMed ID: 19560215
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beneficial actions of oleanolic acid in an experimental model of multiple sclerosis: a potential therapeutic role.
    Martín R; Carvalho-Tavares J; Hernández M; Arnés M; Ruiz-Gutiérrez V; Nieto ML
    Biochem Pharmacol; 2010 Jan; 79(2):198-208. PubMed ID: 19679109
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early life exposure to lipopolysaccharide suppresses experimental autoimmune encephalomyelitis by promoting tolerogenic dendritic cells and regulatory T cells.
    Ellestad KK; Tsutsui S; Noorbakhsh F; Warren KG; Yong VW; Pittman QJ; Power C
    J Immunol; 2009 Jul; 183(1):298-309. PubMed ID: 19542441
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The calcitonin/calcitonin gene related peptide-alpha gene is not required for 1alpha,25-dihydroxyvitamin D3-mediated suppression of experimental autoimmune encephalomyelitis.
    Becklund BR; James BJ; Gagel RF; DeLuca HF
    Arch Biochem Biophys; 2009 Aug; 488(2):105-8. PubMed ID: 19563774
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glucocorticoids in the control of neuroinflammation.
    Tischner D; Reichardt HM
    Mol Cell Endocrinol; 2007 Sep; 275(1-2):62-70. PubMed ID: 17555867
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lessons from multiple sclerosis: models, concepts, observations.
    Wekerle H
    Ann Rheum Dis; 2008 Dec; 67 Suppl 3():iii56-60. PubMed ID: 19022815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral administration of 1,4-aryl-2-mercaptoimidazole inhibits T-cell proliferation and reduces clinical severity in the murine experimental autoimmune encephalomyelitis model.
    Jung EJ; Hur M; Kim YL; Lee GH; Kim J; Kim I; Lee M; Han HK; Kim MS; Hwang S; Kim S; Woo AM; Yoon Y; Park HJ; Won J
    J Pharmacol Exp Ther; 2009 Dec; 331(3):1005-13. PubMed ID: 19741152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.